← SynDRA
MUPIROCIN
SynDRA canonical compound SYN0001570 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | isoleucyl-tRNA synthetase inhibitor |
|---|
| Indication | impetigo |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- isoleucyl-tRNA synthetase inhibitor
- Modulator
- ileS INHIBITOR
Drug classes
- RNA Synthetase Inhibitor Antibacterial
- RNA Synthetase Inhibitors
- Anti-Bacterial Agents
- Anti-Infective Agents
- Enzyme Inhibitors
- Protein Synthesis Inhibitors
ATC classes
- D06A · ANTIBIOTICS FOR TOPICAL USE
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
Cross-references
Synonyms
- mupricin
- pseudomonic acid
- turixin
- mupirocin calcium
- bactroban
- BRL 4910A
- Mupirocine
- Mupirocina
- Bactoderm
- Pseudomonic acid
- Trans-pseudomonic acid
- Turixin
- BRL-4910A
- NSC-759182
- Bactroban
- Centany
- MRC
- Mupirocinum
- Plasimine
- Bactroban Nasal
- Mupirocina [Spanish]
- Mupirocine [French]
- Mupirocinum [Latin]
- Pseudomonic acid A
- Bactroban (TN)
- Centany (TN)
- Mupirocin (USP/INN)
- Mupirocin, 14C-Labeled
- 5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)
- 8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat
- 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
- D0GX863OA5
- mupirocin (usp monograph)
- trans-Pseudomonic acid
- mupirocin (usp impurity)
- NSC 759182
- mupirocin (ep monograph)
- mupirocin (usp-rs)
Reported adverse events
- Rash
- Headache
- Abdominal pain
- Nausea
- Blepharitis
- Cough
- Pharyngitis
- Pruritus
- Respiratory disorder
- Rhinitis
Look up MUPIROCIN in the interactive SynDRA portal →